Molecular Characterization of Human Tryptophan Hydroxylase 2 (hTPH2)
Molecular Characterization of Human Tryptophan Hydroxylase 2 (hTPH2)
批准号:
7777375
负责人:
KENT E VRANA
金额:
$18.74万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-01-01 至 2011-02-28
关键词:
Active SitesAddressAmino Acid SubstitutionAmino AcidsAnabolismAreaAromatic Amino AcidsBase SequenceBiochemicalBiogenic AminesBiological AssayCatecholaminesCell Culture TechniquesCodeCrystallographyDataDevelopmentDiseaseEnzymatic BiochemistryEnzyme StabilityEnzymesFunctional RNAFundingGenesGenetic PolymorphismGoalsGrantHealthHumanImageKineticsKnowledgeLaboratoriesMammalian CellMapsMental DepressionMental HealthMental disordersMixed Function OxygenasesModelingMolecularMolecular ModelsMutagenesisMutationN-terminalNervous system structureNeuraxisPC12 CellsPeripheralPhenylalaninePhosphorylation SitePositioning AttributePublishingRecombinant ProteinsRecording of previous eventsRegulationResearch PersonnelRoleSeminalSerotoninSilent MutationSiteStructureStructure-Activity RelationshipSubstance abuse problemTDO2 geneTestingTimeTryptophanTryptophan 5-monooxygenaseTyrosineTyrosine 3-MonooxygenaseVariantWorkbasedesignenzyme activitygene discoveryhuman tryptophan hydroxylase 2inhibitor/antagonistinsightmolecular modelingmutantnovelprogramsresearch study
中文摘要
描述(由申请人提供):色氨酸羟化酶(TPH)催化5 -羟色胺生物合成的初始和限速步骤。因此,它与各种精神健康障碍有关。这个长期存在的R01的目标之一是更好地了解这种关键酶。然而,在之前的周期中,其他研究人员(以及目前的合作者)发现了这种酶的一种新变体(由一个单独的基因编码),它负责中枢神经系统血清素的合成——TPH2。鉴于该领域的工作迄今为止主要集中于外周酶(现在称为TPH1),并且考虑到中枢神经系统血清素对健康和疾病的重要性,我们建议将即将到来的更新期的重点转移到更好地理解这种新型的关键酶上。实际上,人们对hTPH2的结构、功能和酶学一无所知。与这种新酶的发现者合作,我们建立了对人类TPH2 (hTPH2)的重要的新表征研究。我们完全有能力在本建议中实现三个具体目标。特异性目标1将描述hTPH2基因自然发生多态性的功能后果。在发现TPH2基因的短短几年中,已经描述了七种不同的编码区多态性。关于这些氨基酸取代的后果所知甚少,这一目标将解决这一差距在我们的知识。Aim 2将使用我们从酪氨酸羟化酶和hTPH1中获得的数据来绘制hTPH2的活性位点。这些生化研究将为这种新的重要酶提供重要的功能见解。特异性目的3将探讨hTPH2通过其n端调控域的调控。这些实验将有助于我们了解血清素生物合成在健康和疾病中的动态调节。
英文摘要
DESCRIPTION (provided by applicant): Tryptophan hydroxylase (TPH) catalyzes the initial and rate-limiting step in the biosynthesis of serotonin. As such, it has been implicated in a variety of mental health disorders. One of the goals of this long-standing R01 has been to better understand this pivotal enzyme. However, in the midst of the preceding cycle, other investigators (and current collaborators) made the seminal discovery of a new variant of this enzyme (encoded by a separate gene) that is responsible for central nervous system serotonin synthesis - TPH2. Given that the work in this field had to this point focused on the peripheral enzyme (now termed TPH1), and given the importance of CNS serotonin to health and disease, we propose shifting the emphasis of this upcoming renewal period to better understanding this novel and pivotal enzyme. Virtually nothing is known about the structure, function, and enzymology of hTPH2. Partnering with the discoverers of this new enzyme, we have established important new characterization studies on the human TPH2 (hTPH2). We are strongly positioned to pursue three specific aims in the present proposal. Specific Aim 1 will characterize the functional consequences of naturally-occurring polymorphisms in the hTPH2 gene. In the few short years since discovery of the TPH2 gene, seven different coding region polymorphisms have been described. Little is known concerning the consequences of these amino acid substitutions and this aim will address this gap in our knowledge. Aim 2 will use data we have obtained from tyrosine hydroxylase and hTPH1 to map the active site of hTPH2. These biochemical studies will provide important functional insights into this novel and important enzyme. Specific Aim 3 will explore the regulation of hTPH2 by its N-terminal regulatory domain. These experiments will contribute to our knowledge of the dynamic regulation of serotonin biosynthesis in health and disease.
The novel hTPH2 gene was first described three years ago. Its discovery resolves several important discprepancies in the field of serotonin biosynthese. However, we must establish a deeper understanding of this pivotal enzyme to better appreciate its role in health and disease and to provide a basis for potential development of novel pharmacotherapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A diagnostic plasma protein panel for alcohol abuse
-
批准号:8531534
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2014
-
负责人:KENT E VRANA
-
依托单位:
A diagnostic plasma protein panel for alcohol abuse
-
批准号:8867957
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2014
-
负责人:KENT E VRANA
-
依托单位:
A diagnostic plasma protein panel for alcohol abuse
-
批准号:9035335
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2014
-
负责人:KENT E VRANA
-
依托单位:
Serum Biomarkers of Alcohol Self-Administration in Non-Human Primates
-
批准号:7885706
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2009
-
负责人:KENT E VRANA
-
依托单位:
Serum Biomarkers of Alcohol Self-Administration in Non-Human Primates
-
批准号:7187483
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2007
-
负责人:KENT E VRANA
-
依托单位:
Serum Biomarkers of Alcohol Self-Administration in Non-Human Primates
-
批准号:7338334
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2007
-
负责人:KENT E VRANA
-
依托单位:
Serum Biomarkers of Alcohol Self-Administration in Non-Human Primates
-
批准号:7547094
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2007
-
负责人:KENT E VRANA
-
依托单位:
EPIGENETIC IMPRINTING BY CHRONIC DRUGS OF ABUSE
-
批准号:6564003
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2001
-
负责人:KENT E VRANA
-
依托单位:
EPIGENETIC IMPRINTING BY CHRONIC DRUGS OF ABUSE
-
批准号:6332490
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
FUNCTIONAL GENOMICS OF COCAINE SELF ADMINISTRATION
-
批准号:6379114
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
Functional Genomics of Cocaine Self-Administration
-
批准号:7104824
-
项目类别:
-
资助金额:$25.74万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
EPIGENETIC IMPRINTING BY CHRONIC DRUGS OF ABUSE
-
批准号:6410230
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
Functional Genomics of Cocaine Self-Administration
-
批准号:6806950
-
项目类别:
-
资助金额:$23.43万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
Functional Genomics of Cocaine Self-Administration
-
批准号:6727054
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
FUNCTIONAL GENOMICS OF COCAINE SELF ADMINISTRATION
-
批准号:6291537
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
EPIGENETIC IMPRINTING BY CHRONIC DRUGS OF ABUSE
-
批准号:6300731
-
项目类别:
-
资助金额:$12.78万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
FUNCTIONAL GENOMICS OF COCAINE SELF ADMINISTRATION
-
批准号:6515831
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
Functional Genomics of Cocaine Self-Administration
-
批准号:6949612
-
项目类别:
-
资助金额:$26.36万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
Functional Genomics of Cocaine Self-Administration
-
批准号:6921081
-
项目类别:
-
资助金额:$21.05万
-
财政年份:2000
-
负责人:KENT E VRANA
-
依托单位:
EPIGENETIC IMPRINTING BY CHRONIC DRUGS OF ABUSE
-
批准号:6104018
-
项目类别:
-
资助金额:$12.78万
-
财政年份:1999
-
负责人:KENT E VRANA
-
依托单位:
海外基金